Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT03580837
- Lead Sponsor
- University Hospital, Strasbourg, France
- Brief Summary
The aim of this retrospective study is to evaluate the value of pre-treatment and post-treatment multimodality MRI study, including quantitative evaluation of background parenchymal enhancement, for response prediction and evaluation. This study will include 100 patients treated in a single institution between 2011 and 2016
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Adult patients
- Patients with breast cancer treated with neoadjuvant chemotherapy
- Patients with pre- and post-chemotherapy MRI
- Patients who have given their agreement to use their data for research purposes.
Exclusion Criteria
- Refusal to participate in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of of pathologic enhancement of breast by MRI 1 hour after the realization of the MRI This work concerns 110 patients treated with neoadjuvant chemotherapy for breast cancer and having received a breast MRI in pre and post-chemiotherapy at the Hautepierre Hospital.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Service Imagerie 1
🇫🇷Strasbourg, France